Google Chrome
Safari
Firefox
Edge
Search
Press Release / Nov 11, 2021
Hovione invests $170 million in new capacity and capabilities
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Article / Sep 29, 2015
Hovione to expand its New Jersey facility
Manufacturing Chemist, 29 September 2015
News / Jul 10, 2017
FDA Training at Hovione New Jersey Site
Hovione New Jersey welcomes a team of 8 FDA Reviewers for a training on Quality by Design (QbD)
Dispersome®
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
Press Release / Jun 18, 2024
Hovione Unveils New Continuous Tableting Line at Lisbon R&D Centre
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Press Clipping / Oct 28, 2025
Oct. 28 Business Watch: More plants closing in Europe, Novartis to pay $12 billion for biotech firm
C&EN, 28 October 2025